Ciska Verbaanderd
Impact in
- Physiology top 10%
-
- Computational Drug Discovery Methods
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 7
- Pharmaceutical Economics and Policy 5
-
- Biomedical Ethics and Regulation 5
- Co-authors
- Pan Pantziarka (4 shared papers)Lydie Meheus (4 shared papers)Isabelle Huys (6 shared papers)Gauthier Bouche (3 shared papers)Vidula Sukhatme (2 shared papers)Vikas P. Sukhatme (2 shared papers)Ilse Rooman (3 shared papers)Hannelore Maes (1 shared paper)
- Journals
- Frontiers in Medicine (2 papers)Frontiers in Pharmacology (2 papers)Trends in cancer (1 paper)ESMO Open (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- BelgiumUnited KingdomUnited States
In The Last Decade
Ciska Verbaanderd
12 papers receiving 519 citations
Peers
Comparison fields: 5 of 89
- Physiology 29
- Computational Theory and Mathematics 75
- Cancer Research 69
- Pharmacology 33
- Oncology 100
Countries citing papers authored by Ciska Verbaanderd
This map shows the geographic impact of Ciska Verbaanderd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ciska Verbaanderd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ciska Verbaanderd more than expected).
Fields of papers citing papers by Ciska Verbaanderd
This network shows the impact of papers produced by Ciska Verbaanderd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ciska Verbaanderd. The network helps show where Ciska Verbaanderd may publish in the future.
Co-authors
The 25 scholars most cited alongside Ciska Verbaanderd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 203 | |
| 2 | 2018 | 99 | |
| 3 | 2017 | 61 | |
| 4 | 2020 | 48 | |
| 5 | 2020 | 41 | |
| 6 | 2015 | 21 | |
| 7 | 2021 | 20 | |
| 8 | 2022 | 9 | |
| 9 | 2020 | 8 | |
| 10 | 2022 | 7 | |
| 11 | 2023 | 6 | |
| 12 | 2021 | 3 |
About Ciska Verbaanderd
Ciska Verbaanderd is a scholar working on Economics and Econometrics, Physiology, Pediatrics, Perinatology and Child Health, Molecular Biology and Pathology and Forensic Medicine, having authored 12 papers that have together received 526 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Pharmaceutical Economics and Policy (5 papers), Biomedical Ethics and Regulation (5 papers), Pharmaceutical studies and practices (4 papers), Autophagy in Disease and Therapy (1 paper), Cancer Genomics and Diagnostics (1 paper), Dental Radiography and Imaging (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Physiology (29 citations), Computational Theory and Mathematics (75 citations), Cancer Research (69 citations), Pharmacology (33 citations) and Oncology (100 citations). Ciska Verbaanderd has collaborated with scholars based in Belgium, United Kingdom and United States. Frequent co-authors include Pan Pantziarka, Lydie Meheus, Isabelle Huys, Gauthier Bouche, Vidula Sukhatme, Vikas P. Sukhatme, Ilse Rooman, Hannelore Maes, Marco B.E. Schaaf and Patrizia Agostinis. Their work appears in journals such as Frontiers in Medicine, Frontiers in Pharmacology, Trends in cancer, ESMO Open and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.